Patent Assignment
Reel/Frame 023510/0460
Corrective Assignment to Correct the Patent No. 6613359 to 6613519 and to Correct Application No. 12262184 to 12262384 Previously Recorded on Reel 022331 Frame 0074. Assignor(S) Hereby Confirms the Intellectual Property Security Agreement.
Recorded: 2009-11-13
Received: 2009-11-13
Pages: 15
Assignor
SYNVISTA THERAPEUTICS, INC.
Executed: 2009-02-24
Assignee
BAKER BROS. ADVISORS, LLC, AS COLLATERAL AGENT
667 MADISON AVENUE, 21ST FLOOR, NEW YORK, NY, 10065, UNITED STATES
Covered Properties
(5)
Glycemic Control for Reduction of Cardiovascular Disease Risk in Diabetic Patients Expressing Haptoglobin 2-2
Application:
12/262,384 →
Biaryl Substituted Nitrogen Containing Heterocycle Inhibitors of LTA4H for Treating Inflammation
Application:
11/462,296 →
Angiotensin-(1-7) and Angiotensin-(1-7) Agonists for Inhibition of Cancer Cell Growth
Application:
10/375,733 →
Method of Using Optically-Activated Particles in Cosmetic Preparations
Application:
10/095,669 →
Method of Determining a Risk of Hyperglycemic Patients of Developing a Cardiovascular Disease
Application:
09/815,016 →